Search

Your search keyword '"Bangwen, Eugene"' showing total 6 results
Start Over Author "Bangwen, Eugene"
6 results on '"Bangwen, Eugene"'

1. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo.

Author

Vakaniaki, Emmanuel, Kacita, Cris, Kinganda-Lusamaki, Eddy, OToole, Áine, Wawina-Bokalanga, Tony, Mukadi-Bamuleka, Daniel, Amuri-Aziza, Adrienne, Malyamungu-Bubala, Nadine, Mweshi-Kumbana, Franklin, Mutimbwa-Mambo, Léandre, Belesi-Siangoli, Freddy, Mujula, Yves, Parker, Edyth, Muswamba-Kayembe, Pauline-Chloé, Nundu, Sabin, Lushima, Robert, Makangara-Cigolo, Jean-Claude, Mulopo-Mukanya, Noella, Pukuta-Simbu, Elisabeth, Akil-Bandali, Prince, Kavunga, Hugo, Abdramane, Ombotimbe, Brosius, Isabel, Bangwen, Eugene, Vercauteren, Koen, Sam-Agudu, Nadia, Mills, Edward, Tshiani-Mbaya, Olivier, Hoff, Nicole, Rimoin, Anne, Hensley, Lisa, Kindrachuk, Jason, Baxter, Cheryl, de Oliveira, Tulio, Ayouba, Ahidjo, Peeters, Martine, Delaporte, Eric, Ahuka-Mundeke, Steve, Mohr, Emma, Sullivan, Nancy, Muyembe-Tamfum, Jean-Jacques, Nachega, Jean, Rambaut, Andrew, Liesenborghs, Laurens, and Mbala-Kingebeni, Placide

Subjects
Humans, Democratic Republic of the Congo, Disease Outbreaks, Mpox (monkeypox), Female, Male, Adult, Monkeypox virus, Young Adult, Phylogeny, Adolescent, Animals, Middle Aged, Genome, Viral, Mutation, Child
Abstract

Outbreaks of monkeypox (mpox) have historically resulted from zoonotic spillover of clade I monkeypox virus (MPXV) in Central Africa and clade II MPXV in West Africa. In 2022, subclade IIb caused a global epidemic linked to transmission through sexual contact. Here we describe the epidemiological and genomic features of an mpox outbreak in a mining region in eastern Democratic Republic of the Congo, caused by clade I MPXV. Surveillance data collected between September 2023 and January 2024 identified 241 suspected cases. Genomic analysis demonstrates a distinct clade I lineage divergent from previously circulating strains in the Democratic Republic of the Congo. Of the 108 polymerase chain reaction-confirmed mpox cases, the median age of individuals was 22 years, 51.9% were female and 29% were sex workers, suggesting a potential role for sexual transmission. The predominance of APOBEC3-type mutations and the estimated emergence time around mid-September 2023 imply recent sustained human-to-human transmission.

Published
2024

2. Co-Circulating Monkeypox and Swinepox Viruses, Democratic Republic of the Congo, 2022.

Author

Kalonji, Thierry, Malembi, Emile, Matela, Jean, Likafi, Toutou, Kinganda-Lusamaki, Eddy, Vakaniaki, Emmanuel, Hoff, Nicole, Aziza, Amuri, Muyembe, Francisca, Kabamba, Joelle, Cooreman, Tine, Nguete, Béatrice, Witte, Danae, Ayouba, Ahidjo, Fernandez-Nuñez, Nicolas, Roge, Stijn, Peeters, Martine, Merritt, Sydney, Ahuka-Mundeke, Steve, Delaporte, Eric, Pukuta, Elisabeth, Mariën, Joachim, Bangwen, Eugene, Lakin, Steven, Lewis, Charles, Doty, Jeffrey, Liesenborghs, Laurens, Hensley, Lisa, McCollum, Andrea, Rimoin, Anne, Muyembe-Tamfum, Jean, Shongo, Robert, Kaba, Didine, and Mbala-Kingebeni, Placide

Subjects
Democratic Republic of the Congo, One Health, infectious diseases, monkeypox virus, mpox, orthopoxvirus, outbreak investigation, sexually transmitted infections, swinepox, swinepox virus, vector-borne infections, viruses, zoonoses, Humans, Animals, Swine, Mpox (monkeypox), Monkeypox virus, Suipoxvirus, Democratic Republic of the Congo, Poxviridae
Abstract

In September 2022, deaths of pigs manifesting pox-like lesions caused by swinepox virus were reported in Tshuapa Province, Democratic Republic of the Congo. Two human mpox cases were found concurrently in the surrounding community. Specific diagnostics and robust sequencing are needed to characterize multiple poxviruses and prevent potential poxvirus transmission.

Published
2024

3. Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study

Author

De Vos, Elise, Van Gestel, Liesbeth, Brosius, Isabel, Kenyon, Chris, Vuylsteke, Bea, De Baetselier, Irith, Mariën, Joachim, Bangwen, Eugene, Couvreur, Simon, Lecompte, Amaryl, Van Beckhoven, Dominique, Hoorelbeke, Bart, Verstrepen, Babs E., Zaeck, Luca M., de Vries, Rory D., Geurts van Kessel, Corine H., Hens, Niel, Ariën, Kevin K., Vercauteren, Koen, Van Esbroek, Marjan, Van Dijck, Christophe, and Liesenborghs, Laurens

Published
2024
Full Text
View/download PDF

5. Potential determinants of the decline in mpox cases in Belgium:A behavioral, epidemiological and seroprevalence study

Author

De Vos, Elise, Van Gestel, Liesbeth, Brosius, Isabel, Kenyon, Chris, Vuylsteke, Bea, De Baetselier, Irith, Mariën, Joachim, Bangwen, Eugene, Couvreur, Simon, Lecompte, Amaryl, Van Beckhoven, Dominique, Hoorelbeke, Bart, Verstrepen, Babs E., Zaeck, Luca M., de Vries, Rory D., Geurts van Kessel, Corine H., Hens, Niel, Ariën, Kevin K., Vercauteren, Koen, Van Esbroek, Marjan, Van Dijck, Christophe, Liesenborghs, Laurens, De Vos, Elise, Van Gestel, Liesbeth, Brosius, Isabel, Kenyon, Chris, Vuylsteke, Bea, De Baetselier, Irith, Mariën, Joachim, Bangwen, Eugene, Couvreur, Simon, Lecompte, Amaryl, Van Beckhoven, Dominique, Hoorelbeke, Bart, Verstrepen, Babs E., Zaeck, Luca M., de Vries, Rory D., Geurts van Kessel, Corine H., Hens, Niel, Ariën, Kevin K., Vercauteren, Koen, Van Esbroek, Marjan, Van Dijck, Christophe, and Liesenborghs, Laurens

Abstract

Objectives: The 2022 mpox epidemic reached a peak in Belgium and the rest of Europe in July 2022, after which it unexpectedly subsided. This study investigates epidemiological, behavioral, and immunological factors behind the waning of the epidemic in Belgium. Methods: We investigated temporal evolutions in the characteristics and behavior of mpox patients using national surveillance data and data from a prospective registry of mpox patients in the Institute of Tropical Medicine (Antwerp). We studied behavioral changes in the population at risk using a survey among HIV-preexposure prophylaxis (PrEP) users. We determined the seroprevalence of anti-orthopoxvirus antibodies among HIV-PrEP users across four-time points in 2022. Results: Mpox patients diagnosed at the end of the epidemic had less sexual risk behavior compared to those diagnosed earlier: they engaged less in sex at mass events, had fewer sexual partners, and were less likely to belong to the sexual network's central group. Among HIV-PrEP users there were no notable changes in sexual behavior. Anti-orthopoxvirus seroprevalence did not notably increase before the start of national vaccination campaigns. Conclusion: The observed changes in group immunity and behavior in the population at greater risk of exposure to mpox seem unable to explain the waning of the mpox epidemic. A change in the profile of mpox patients might have contributed to the decline in cases.

Published
2024

6. Presymptomatic viral shedding in high‐risk mpox contacts: A prospective cohort study.

Author

Brosius, Isabel, Dijck, Christophe Van, Coppens, Jasmine, Vandenhove, Leen, Bangwen, Eugene, Vanroye, Fien, Verschueren, Jacob, Zange, Sabine, Bugert, Joachim, Michiels, Johan, Bottieau, Emmanuel, Soentjens, Patrick, van Griensven, Johan, Kenyon, Chris, Ariën, Kevin K., Esbroeck, Marjan Van, Vercauteren, Koen, and Liesenborghs, Laurens

Subjects
MONKEYPOX, VIRAL shedding, COHORT analysis, VIRAL DNA, LONGITUDINAL method
Abstract

The risk of infection after exposure to clade IIb mpox virus (MPXV) is unknown, and potential presymptomatic shedding of MPXV remains to be demonstrated. High‐risk contacts of mpox patients were followed‐up in a prospective longitudinal cohort study. Individuals reporting sexual contact, >15 min skin‐to‐skin contact, or living in the same household with an mpox patient were recruited in a sexual health clinic in Antwerp, Belgium. Participants kept a symptom diary, performed daily self‐sampling (anorectal, genital, and saliva), and presented for weekly clinic visits for physical examination and sampling (blood and oropharyngeal). Samples were tested for MPXV by PCR. Between June 24 and July 31, 2022, 25 contacts were included, of which 12/18 (66.0%) sexual and 1/7 (14.0%) nonsexual contacts showed evidence of infection by MPXV‐PCR. Six cases had typical mpox symptoms. Viral DNA was detected as early as 4 days before symptom onset in 5 of them. In 3 of these cases, replication‐competent virus was demonstrated in the presymptomatic phase. These findings confirm the existence of presymptomatic shedding of replication‐competent MPXV and emphasize the high risk of transmission during sexual contact. Sexual contacts of mpox cases should abstain from sex during the incubation period, irrespective of symptoms. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results